Imaging stocks eye US veterans health market
With their innovative tech, ASX medical imaging companies are capitalising on the lucrative opportunity of caring for US veterans.
News
Uscom, Respiri lead slow sector
Uscom and Respiri lead a sluggish ASX healthcare sector, as Saxo Markets’ Jessica Amir cautions that ‘time in the market, not timing, is key’.
Two-pronged plan to put ‘mozz’ on dengue fever
With dengue fever spreading to colder climates, Island Pharmaceuticals is working on a preventative and therapeutic solution to a complex problem.
Iron ore death rumours greatly exaggerated
Former Rio and Arcelor Mittal man Paul Berend – now heading Cyclone Metals – says the iron ore outlook for new developers is brighter than many think. Here’s why.
ASX explorers rise on project milestones
BMG says it’s fully-funded to expand the 518,000oz gold resource at Abercromby and both Bubalus and Talga rise on environmental wins.
Break it Down: St Barbara’s raise
In this episode, host Fraser Palamara details how gold miner St Barbara plans to spend the $110 million it’s raising for the Simberi project.
Cancer fighter looks beyond ‘low-hanging fruit’
Chimeric Therapeutics has struck major blows against blood cancer, but as it plans a homecoming it is taking aim at tougher targets, with its next-gen Car-T drugs.
Closing Bell: ASX slips as RBA holds rates
Aussie shares have dipped on Tuesday as RBA holds rates, MinRes rebounds, and Kamala Harris leads in Iowa.
Biotech firms face ‘second strike’ risk
Several biotech companies are at risk of a remuneration report ‘second strike’ and subsequent board spill motion.
Stocks down, all eyes on RBA and Vauban.
The ASX starts sluggish with eyes on the RBA and Melbourne Cup; Domino’s drops as Mineral Resources rises.
Break it Down: Veni, vidi, vici
Augustus Minerals has acquired a new gold project north of Leonora in Western Australia amongst some big hitters.
Aussie firm leads Nasdaq; Reddit shines
As US election week jitters markets, Reddit is celebrating its first-ever profit. Meanwhile an under-the-radar Aussie company is sizzling on Wall Street.
Market likes look of critical minerals
As we look towards a clean energy future, critical minerals stocks rank up on October’s resources winners list. And, of course, gold was looking good too.
ASX tech sector’s surge off-line in October
The S&P/ASX 200 Information Technology sector is down … and up. It fell 4.43 per cent in October but remains the ASX’s top performer, up 41.95 per cent YTD.
MinRes shares sink on Ellison decision
Mineral Resources will chase a successor for Chris Ellison after governance issues come back to bite.
ASX explorers making gains
Western Gold shovel ready after DEMIRS approvals, Blue Star balloons on 50% helium farm-out and Ordell hits gold at Barimaia.
Adisyn buys semiconductor tech company 2D Generation
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the acquisition of a semiconductor IP business from Adisyn.
Hipages plans reno for tradies market
With a key financial metric in mind, Hipages, is set on company growth by making it easier for homeowners to connect with skilled tradies.
Ruling gives nuclear medicine stocks warm glow
A US reimbursement decision that protects radiopharmacy leader Telix Pharmaceuticals has been hailed as ‘a major win for the molecular imaging industry’.
Patronus Resources’ makes moves on gold project
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing a Northern Territory Government approval for Patronus Resources’ gold project.
Why pain can turn to gain for lithium prices
We may be far off from the boom times for lithium, but low prices could boost EV and energy storage demand, bringing the rebound forward.
Geopacific’s golden PNG situation
Barry FitzGerald casts his eye over Geopacific Resources and the competitive tension on the PNG gold explorer’s register.
ASX October 2024 winners
After five consecutive months of gains, the S&P/ASX 200 fell 1.3 per cent in October, erasing Spring optimism that had lifted the benchmark by 3 per cent in September.
Only gold shines in red October for metals
Only gold and silver powered to gains of the metals tracked by Stockhead’s Up, Up, Down, Down column, as China’s stimulus bump wore off.
Brightstar walking in the footsteps of giants
Quietly growing from a market cap of $7m to $170m, Alex Rovira’s gold explorer Brightstar Resources is showing major ambition, reports Kristie Batten.
It’s getting hot in here for investors
Investors are increasingly worried about frothy valuations, but the trends are inconsistent. Tim Boreham explains.
Time to add bonds to your investment mix
Interest rates have soared in recent years and this fundie suggests the time is right to consider bonds as an alternative to term deposits.
Tony’s Takeaway: Is the bull market back?
While we could be back in a small caps bull market, Tony Locantro says hold your horses as he gives you a 101 on the psychology of speculation.
Macquarie drags banks; Ironbark Zinc soars
ASX starts November down as Macquarie profits fall, and Ironbark Zinc soars on new famed exec chairman.
Uptober lifts Bitcoin to Moonvember
Bitcoin and crypto get an ‘Uptober’ after all as November’s moon mission prepares for lift-off.
Healthcare sector has pre-election jitters
Morgans healthcare analyst Scott Power says markets appear to be suffering from US pre-election jitters – not helped by a mixed quarterly reporting season.
Ethical Aussies’ views shifting on …. mining?
Public trust in the mining industry is increasing as support for mining aligns with renewable energy goals.
Russian gold boss gives Ironbark bump
The former CEO of Russian gold miner Nordgold has emerged as the new lynchpin at Ironbark Zinc.
Taking healthcare digital to fill labour gaps
From remote monitoring of maternity patients to digital pathology, these ASX companies are tackling healthcare labour shortages with technology.
Local markets sag… thanks Wall Street
The ASX 200 is down about 1.0% this morning, after Wall Street was hit by a massive tech sell-down overnight.
Capricorn Metals raises $200M for gold projects
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new capital raise from Capricorn Metals.
Astral Resources’ auric enhancement
Stockhead TV brings you today’s Break it Down, detailing Astral’s Feysville gold group upgrade which brings it close to 1.5Moz.
US tech stocks tumble; oil jumps
A big day on Wall Street as tech stocks mainly slump. Robinhood plunges, but Amazon soars and shares of Roblox and Peloton surge.
ASX September quarterly health wrap
Dimerix, Paradigm and Blinklab are among ASX health companies reporting quarterly results this week.
MinRes and Hancock cook up gas deal
Hancock has dropped major cash on MinRes’ Perth Basin gas. How does it stack up for value?
‘At these lithium prices nobody’s making money’
Pilbara, Liontown, IGO and MinRes have all reported their quarterly results. Just how badly are weak prices hurting lithium miners? We investigate.
Why Taroom Trough is ‘a gas play to watch’
Promising gas exploration is feeding hopes the Taroom Trough could ease the East Coast gas supply shortfall flagged by the Australian Energy Marketing Operator.
ASX dips; Talga soars as Sweden greenlights graphite mine
The ASX slipped, with AGL falling over 6% following a downgrade, while Talga has the permission from Sweden to mine.
Guy on Rocks: Bouldering with Guy
This week on Guy on Rocks, host Guy Le Page puts West Australian goldie Great Boulder Resources under the microscope.
Swedish court backs Talga graphite
Talga has enviromental approval for the Nunasvaara South natural graphite mine, part of its Vittangi anode project in Sweden. Read more in our resources wrap.
Lunch Wrap: ASX benchmark feeling a little down
The ASX was down about 0.5 per cent around lunch on Thursday, with a mix of company meetings and earnings updates keeping the index in check.
Break it Down: St George Mining
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new memorandum of understanding for the Araxá project from St George Mining.
We have prescription for growth: PharmX
An intermediary in the chemist supply chain, PharmX flags solid revenue growth despite already dominating the market. Here’s your health wrap.
Break it Down: Toubani Resources
Sarah Hughan digs into a definitive feasibility study from Toubani Resources which showed off Kobada as a highly attractive project of scale.
BHP maintains optimism on China
BHP’s top brass remain China bulls, saying steel demand has moved from its flagging property sector to green technologies like EVs, solar panels and wind turbines.
Breaking Out: Antimony grades put eyes on Octava
Steve Collette takes the technical pulse of Octava Minerals, up over 230% in six months thanks to its antimony potential.
Meta disappoints as Super Micro plummets
Meta’s disappointing projections frustrated investors while Microsoft impressed, and Super Micro plunged 33% after auditor resigned.
ASX newcomer out to weave global reputation
Merino & Co rose 17.5 per cent on its ASX listing on Wednesday, but its ambition goes way beyond that. It wants to wool’s version of R.M. Williams – a global icon.
Gold ETF revival spurs demand record
The World Gold Council says demand for the yellow metal hit a third quarter record this year as inflows returned to Western ETFs.
ASX dips, Woolies warns, GCM triples
The ASX plunged after supermarket stocks slumped on a Woolies warning; and GCM ticker surges 200pc on graphite tech deal.
Break it Down: Tryptamine Therapeutics
In this episode, host Fraser Palamara dissects the $6 million raising completed today by biotech company Tryptamine Therapeutics.
PLS flags lithium cuts
Pilbara Minerals will cut output at Pilgangoora and pause a processing plant, warning a sizeable portion of lithium supply is loss-making.
Zip rocketing. So, is BNPL making a comeback?
Zip’s stock has soared 830 per cent in the 12 months since new CEO Cynthia Scott’s strategic shift, raising hopes for a ‘buy now, pay later” sector rebound.
ASX small caps lunch wrap
The ASX has pared gains at lunch time in the eastern states, after better-than-expected inflation numbers.
Could this tech shake up graphite sector?
Green Critical Minerals acquires revolutionary technology to produce VHD graphite, which can be used in a wide variety of applications. Read more in our resources wrap.
News is all good for these clinical trials
A rash of September quarter updates show that a number of drug and device plays are making encouraging clinical progress as they seek to save, and improve lives.
Break it Down: Challenger Gold
Host Fraser Palamara explains why it’s a momentous occasion for Argentinian explorer Challenger Gold today in San Juan.
Alphabet, Reddit, Bitcoin surge as Nasdaq peaks
ASX expected to rise after Nasdaq’s record high, while Bitcoin gains amid bullish sentiment from Trump’s potential election win.
Golden Horse gallops toward ASX listing
Golden Horse believes its tenure, the largest known consolidation over the Southern Cross greenstone belt in history, will prove irresistible to gold-hungry investors.
Three ASX quarterly health stars
HeraMed, Lumos Diagnostics and LTR Pharma are among ASX health companies reporting strong quarterly results this week.
Unleashing the power of light on cancer
Invion Therapeutics is deploying little-known – but age-old – photodynamic therapies to tackle solid tumours, in its quest for a shining example of affordable treatment.
Manuka Resources’ maiden silver ore reserve
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the Wonawinta silver mine in New South Wales’ ore reserve from Manuka Resources.
Top 10 at 11: Fresh from the ASX today
Good morning, and welcome to Stockhead’s Top 10 at 11, a short, sharp update to help frame the trading day.
All you need to know before the ASX opens
Good morning, and Happy Tuesday! Here’s everything you need to know, and some things you don’t, before the ASX opens today.
Closing Bell: Myer-Premier deal excites market
In Tuesday action, Cettire fell 12 per cent after a poor quarter, while Premier Investments soared on news of a potential Myer deal.
Break it Down: Fibromyalgia hope from Tryptamine Therapeutics
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new promising trial results from Tryptamine Therapeutics.
ASX up slightly as Myer goes shopping
The ASX 200 was up modestly at lunchtime, as the goldies, banks and Real Estate performed and Premier Investments jumped on Myer news.
Scorpion piques investor interest in WA
The long-term thematic for copper and record gold prices are creating a perfect storm for Scorpion Minerals and its Pharos project, which has both commodities.
Recharge Metals takes on US uranium project
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new Carter uranium project acquisition from Recharge Metals.
Nothing to spook investors, says CSL
Blood products giant CSL says current-year earnings should come in 10-13 per cent higher, despite its moves to taper capital expenditure. Here’s your health wrap.
Nuclear medicine play poised to boom
An Australian invention, Cyclopharm’s lung imaging tool Technegas looks to have all the boxes ticked for success in the US.
Wall Street hypes Big Tech earnings
The ASX is expected to rise as Wall Street gains, driven by upcoming tech earnings, and Altman’s nuclear startup soars.
Sarama seeks justice for gold ‘expropriation’
A Canadian-Australian explorer which claims a gold mine was expropriated by Burkina Faso has secured funding – and a top-gun lawyer – in a campaign for compensation.
Nvidia tops Apple, investors eye poll volatility
Wall Street has pulled back after a strong rally, with Nvidia surpassing Apple as most valuable company. Meanwhile, investors brace for election volatility.
On the lookout for rare earth opportunities
Veteran mining columnist Barry FitzGerald saw a recovery in rare earths starting to gain momentum. So he went searching for some ASX stocks set to benefit …
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/27